CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval for Licensing of 16 Additional Cultivation Rooms Under Cannabis Regulations
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “company” or “Organigram”), a leading licensed producer of cannabis, today announced the company’s receipt of Health Canada’s approval for the licensing of 16 additional cultivation rooms under the Cannabis Regulations. According to the update, the expanded license was effective as of December 12, 2019, and the new cultivation rooms represent approximately 13,000 kg/yr1 of increased target cultivation capacity. “This is a dynamic time for Organigram and the industry as a whole. Cannabis 2.0 – the legalization of adult use recreational cannabis edibles, vape products, extracts and topicals – is a new era for cannabis here at home and around the world,” Organigram CEO Greg Engel said in the news release. “Our physical expansion reflects our ambitious response to this new opportunity as well as our ongoing commitment to anticipating and meeting the demands of Canadian cannabis consumers for new and innovative cannabis experiences.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “company” or “Organigram”), a leading licensed producer of cannabis, today announced the company’s receipt of Health Canada’s approval for the licensing of 16 additional cultivation rooms under the Cannabis Regulations. According to the update, the expanded license was effective as of December 12, 2019, and the new cultivation rooms represent approximately 13,000 kg/yr1 of increased target cultivation capacity. “This is a dynamic time for Organigram and the industry as a whole. Cannabis 2.0 – the legalization of adult use recreational cannabis edibles, vape products, extracts and topicals – is a new era for cannabis here at home and around the world,” Organigram CEO Greg Engel said in the news release. “Our physical expansion reflects our ambitious response to this new opportunity as well as our ongoing commitment to anticipating and meeting the demands of Canadian cannabis consumers for new and innovative cannabis experiences.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
